Currently viewing the tag: "National Toxicology Program (NTP)"

Autoimmune Diseases

by Dr. Thomas K. Lo

According to the American Autoimmune Related Diseases Association (AARDA), autoimmune disease happens to be one of the top ten leading causes of death in females of all age groups up to sixty-four years of age.

The National Institutes of Health (NIH) estimates up to 23.5 million Americans suffer from autoimmune disease and that the prevalence is rising. The AARDA states that it is more like 50 million Americans suffer from autoimmune disease. According to AARDA, the discrepancy is because the NIH numbers only include twenty-four diseases for which good epidemiology studies were available.

Autoimmune diseases result from a dysfunction of the immune system. The immune system protects you from disease and infection. Sometimes, though, the immune system can produce autoantibodies that attack healthy cells, tissues, and organs. This can lead to autoimmune disease and can affect any part of the body. More than eighty autoimmune diseases have been identified; some are relatively well known, such as type 1 diabetes, multiple sclerosis, lupus, and rheumatoid arthritis, while others are rare and difficult to diagnose.

Some autoimmune diseases are life threatening; most are debilitating, requiring a lifetime of treatment. There are treatments available to reduce the many symptoms and effects of autoimmune diseases, but most autoimmune diseases are rare and patients can often spend years seeking a proper diagnosis. Unfortunately, commonly used immunosuppressant treatments can lead to devastating long-term side effects.

The causes of autoimmune diseases remain largely unknown. There is growing consensus that autoimmune diseases likely result from interactions between genetic and environmental factors. The National Institute of Environmental Health Sciences (NIEHS) is supporting research to understand how these factors work together to compromise the body’s ability to defend itself and develop into autoimmune diseases.

Unraveling the connections between genetic predisposition and environmental triggers is a major focus for NIEHS and the National Toxicology Program (NTP), an interagency testing program headquartered at NIEHS. The good news is that progress is being made through multiple research efforts, some of which are noted below.

A 2012 study by NIEHS researchers found that over thirty-two million people in the United States have autoantibodies. Earlier studies have shown that autoantibodies can develop many years before the clinical appearance of autoimmune diseases. The study, which looked at the most common autoantibodies, antinuclear antibodies, found that they are most prevalent among women. This research suggests that the hormones, estrogen and progesterone might be affecting the immune system.

A study of residents in Libby, Montana, who have experienced significant exposure to asbestos minerals due to mining in the area, suggested a link between asbestos exposure and lesions in the lungs. Sixty-one percent of Libby residents tested had autoantibodies and were more likely to have two types of lung abnormalities.

An NIEHS study also found an association between ultraviolet radiation from sunlight and the development of an autoimmune muscle disease, myositis, particularly in women.

Low birth weight and low socioeconomic factors in childhood were associated with the later development of rheumatoid arthritis as an adult.

Recognizing that individuals are rarely exposed to one chemical at a time, NIEHS grantees studied what happens when mice are exposed to two suspected triggers for autoimmune diseases. Previous studies had shown that exposure to trichloroethylene, a solvent and degreasing compound, induced autoimmune hepatitis in autoimmune-prone mice. This study found that when the mice were also exposed to mercuric chloride, a compound used as a disinfectant and also used in photography, disease development accelerated, and a unique liver-specific autoantibody response occurred.

NIEHS grantees studying blood samples of Brazilian mothers exposed to methylmercury, an environmental contaminant passed on to humans by eating contaminated fish, found elevated levels of autoantibodies in the blood of both mothers and their fetuses.

NIEHS and NTP researchers demonstrated that a certain enzyme creates mutations in DNA and is a major player in the development of autoantibodies. The discovery of the role of this enzyme establishes it as a potential target for therapy in autoimmune disorders, such as lupus.

NIEHS brought together an interdisciplinary group of experts to evaluate the state of the science regarding the role of the environment and the development of autoimmune diseases. The experts have identified future research directions, identifying promising mechanistic theories and animal models, and identifying some specific environmental agents that may be involved in the development of autoimmune diseases. The findings included:

(1) Exposure to solvents, which are used in thousands of products, including paint thinners, cleaning supplies, and nail polish, contributes to the development of systemic sclerosis.

(2) Smoking contributes to the development of two types of rheumatoid arthritis.

(3) Exposure to fine particles of crystalline silica, a basic component of quartz, granite, and many other minerals, contributes to the development of several autoimmune diseases. Workers exposed to these minerals are particularly at risk.

(4) Eating gluten, present in wheat and some other grains, contributes to the development of celiac disease, a disorder that affects the small intestine and commonly causes chronic diarrhea and fatigue.

If you feel you are dealing with an autoimmune issue, call the Advanced Chiropractic & Nutritional Healing Center at 240-651-1650. Dr. Lo uses a non-invasive way of analyzing the body to determine the underlying causes of illness, aches and pains. They also offer free seminars, held at the office on rotating Tuesdays and Thursdays. The office is located in Frederick. Check out the website at www.doctorlo.com.